Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

ClinicalTrials.gov ID: NCT07881458

Public ClinicalTrials.gov record NCT07881458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study to Investigate the Efficacy and Safety of LY900043 in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the efficacy and safety of eloralintide and tirzepatide coformulation (EloraTZP) compared to tirzepatide for body weight reduction in participants with obesity or overweight and type 2 diabetes. Participation in the study will last about 2 years.

Study identification

NCT ID
NCT07881458
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2026 (Estimated)
Primary completion
Oct 2029 (Estimated)
Completion
Nov 2029 (Estimated)
Last update posted
Oct 19, 2026

2026 – 2029

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Tucson Clinical Research Institute Tucson Arizona 85712 —
Pacific Clinical Studies Inc. Los Alamitos California 90720 —
Los Angeles Institute for Metabolic Research Los Angeles California 90015 —
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 —
American Research Centers of Florida Pembroke Pines Florida 33027 —
Encore Medical Research - Weston Weston Florida 33331 —
Care Access - Dalton - Clinical Trials Center by Walmart & Care Access Dalton Georgia 30720 —
Pacific Diabetes & Endocrine Center Honolulu Hawaii 96817 —
DM Clinical Research - Indianapolis Indianapolis Indiana 46254 —
Care Access - Eunice Eunice Louisiana 70535 —
Tandem Clinical Research Marrero Louisiana 70072 —
Care Access - St. Louis St Louis Missouri 63131 —
IMA Clinical Research Warren Warren Township New Jersey 07059 —
NYC Research New York New York 10016 —
IMA Clinical Research NYC Midtown New York New York 10036 —
IMA Clinical Research Austin Austin Texas 78745 —
Diabetes and Thyroid Center of Ft. Worth Fort Worth Texas 76132 —
Juno Research Houston Texas 77040 —
Care Access - Houston - Clinical Trials Center by Walmart & Care Access Houston Texas 77082 —
ERA Health Research-Texas Midland Texas 79707 —
Texas Valley Clinical Research (TVCR) - Mission Mission Texas 78572 —
IMA Clinical Research San Antonio San Antonio Texas 78229 —
Care Access - Tyler - Clinical Trials Center by Walmart & Care Access Tyler Texas 75704 —
Washington Center for Weight Management and Research Arlington Virginia 22206 —
Eastside Research Associates Redmond Washington 98052 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07881458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07881458 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →